1. Home
  2. CRNX vs SKYH Comparison

CRNX vs SKYH Comparison

Compare CRNX & SKYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRNX
  • SKYH
  • Stock Information
  • Founded
  • CRNX 2008
  • SKYH 2017
  • Country
  • CRNX United States
  • SKYH United States
  • Employees
  • CRNX N/A
  • SKYH N/A
  • Industry
  • CRNX Biotechnology: Pharmaceutical Preparations
  • SKYH Military/Government/Technical
  • Sector
  • CRNX Health Care
  • SKYH Industrials
  • Exchange
  • CRNX Nasdaq
  • SKYH Nasdaq
  • Market Cap
  • CRNX 4.1B
  • SKYH 324.6M
  • IPO Year
  • CRNX 2018
  • SKYH N/A
  • Fundamental
  • Price
  • CRNX $44.73
  • SKYH $8.92
  • Analyst Decision
  • CRNX Buy
  • SKYH Strong Buy
  • Analyst Count
  • CRNX 11
  • SKYH 3
  • Target Price
  • CRNX $71.00
  • SKYH $13.83
  • AVG Volume (30 Days)
  • CRNX 1.5M
  • SKYH 113.5K
  • Earning Date
  • CRNX 11-06-2025
  • SKYH 11-12-2025
  • Dividend Yield
  • CRNX N/A
  • SKYH N/A
  • EPS Growth
  • CRNX N/A
  • SKYH N/A
  • EPS
  • CRNX N/A
  • SKYH N/A
  • Revenue
  • CRNX $1,535,000.00
  • SKYH $24,125,000.00
  • Revenue This Year
  • CRNX $405.68
  • SKYH $105.29
  • Revenue Next Year
  • CRNX $1,034.87
  • SKYH $86.48
  • P/E Ratio
  • CRNX N/A
  • SKYH N/A
  • Revenue Growth
  • CRNX 47.74
  • SKYH 95.23
  • 52 Week Low
  • CRNX $24.10
  • SKYH $8.22
  • 52 Week High
  • CRNX $60.34
  • SKYH $14.52
  • Technical
  • Relative Strength Index (RSI)
  • CRNX 58.89
  • SKYH 40.79
  • Support Level
  • CRNX $41.51
  • SKYH $8.22
  • Resistance Level
  • CRNX $45.16
  • SKYH $9.10
  • Average True Range (ATR)
  • CRNX 2.05
  • SKYH 0.41
  • MACD
  • CRNX 0.08
  • SKYH -0.09
  • Stochastic Oscillator
  • CRNX 93.77
  • SKYH 40.00

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.

About SKYH Sky Harbour Group Corporation

Sky Harbour Group Corp is an aviation infrastructure company building a nationwide network of Home-based solutions for business aircraft. The company develops, leases, and manages business aviation hangars across the United States based on its proprietary targeting and acquisition model, targeting airfields with hangar supply and demand imbalances in the markets. Its hangar campuses feature exclusive private hangars and a full suite of dedicated services specifically designed for home-based aircraft.

Share on Social Networks: